Negotiable: AstraZeneca : Job Opportunity: Executive Director, In Silico Biologics Discovery Location: Cambridge - UK (Granta Park / Cambridge Biomedical Campus) / Gaithersbur Cambridgeshire, England

Notice NOT-HD-23-020 from the NIH Guide for Grants and Contracts

Notice NOT-HD-23-023 from the NIH Guide for Grants and Contracts

Notice NOT-HD-23-022 from the NIH Guide for Grants and Contracts

Notice NOT-AG-23-042 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-24-063 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research focusing on the identification of druggable new targets and discovery of optimizable probes for development of safe and efficacious medications to prevent and treat opioid use disorders (OUDs), opioid overdose, and opioid-polysubstance use comorbidities. This notice of funding opportunity is part of the NIH Helping to End Addictions Long-term (HEAL) initiative to accelerate the development of novel medications to treat all aspects of the opioid addiction cycle, including progression to chronic use, withdrawal symptoms, craving, relapse, and overdose.

Funding Opportunity RFA-DA-24-064 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research focusing on the identification of druggable new targets and discovery of optimizable probes for development of safe and efficacious medications to prevent and treat opioid use disorders (OUDs), opioid overdose, and opioid-polysubstance use comorbidities. This notice of funding opportunity is part of the NIH Helping to End Addictions Long-term (HEAL) initiative to accelerate the development of novel medications to treat all aspects of the opioid addiction cycle, including progression to chronic use, withdrawal symptoms, craving, relapse, and overdose.

Funding Opportunity RFA-AG-24-050 from the NIH Guide for Grants and Contracts. This NOFO invites R61/R33 applications that address health equity, drug costs, and access to new therapeutics or repurposed drugs for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Successful applications will seek to identify preferences for pharmacological treatment among racial and ethnic minority people living with AD/ADRD, assess whether cost barriers to pharmacological care exist for racial and ethnic minority people living with AD/ADRD, and quantify expenditures and health- related quality of life (HRQoL) among people interested in receiving novel or repurposed drugs for AD/ADRD. This NOFO will support a study development phase (R61) to conduct rigorous stakeholder engagement with racial and ethnic minority groups to identify, measure, and assess the demand for new and repurposed drugs, and if successful, grantees will transition to an R33 phase for implementation of rigorous modeling of costs and health-related quality of life and dissemination of model findings.

Funding Opportunity RFA-DA-25-014 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement is to generate brain region and cell-type specific microglial protein profiles in the context of HIV and SUD, then use those molecular profiles and interaction networks to establish mechanisms of how HIV-harboring microglia may contribute specifically to neuropathologies encountered with comorbid HIV and SUD.

Funding Opportunity PAR-23-239 from the NIH Guide for Grants and Contracts. This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on research that identifies neurobiological and environmental mechanisms associated with social isolation and loneliness that increase risk for suicidal thoughts and behavior in late-life, that uses an experimental therapeutics approach to identify targets and develop and test interventions to prevent late-life suicide, and that develops new and modifies existing service delivery models to enhance social connection in late-life to prevent suicide.

Funding Opportunity PAR-23-238 from the NIH Guide for Grants and Contracts. This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on research that identifies neurobiological and environmental mechanisms associated with social isolation and loneliness that increase risk for suicidal thoughts and behavior in late-life, that uses an experimental therapeutics approach to identify targets and develop and test interventions to prevent late-life suicide, and that develops new and modifies existing service delivery models to enhance social connection in late-life to prevent suicide.

Notice NOT-MD-23-016 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-25-020 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services.

Funding Opportunity RFA-DA-25-019 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services.

Represent Data Management in governance bodies, product teams and cross-functional groups; lead internal working groups. BA/BS in relevant field. $119,000 - $154,000 a year
From Seagen - Wed, 19 Jul 2023 00:12:08 GMT - View all Bothell, WA jobs

Experience in the fleld of molecular and cellular biology (e.g. CRISPR-genome editing, Molecular cloning with SnapGene program, WB/IP/ChIP analysis, Confocal… $54,840 - $66,600 a year
From Washington State University - Tue, 18 Jul 2023 20:58:56 GMT - View all Spokane, WA jobs

30% Prepares specimens for scientific examination and analysis and/or prepares the laboratory for accreditation audits/inspections. $62,000 a year
From University of Wisconsin–Madison - Tue, 18 Jul 2023 18:58:20 GMT - View all Madison, WI jobs

Notice NOT-MH-23-200 from the NIH Guide for Grants and Contracts

£55000 - £65000 per annum: Hyper Recruitment Solutions (HRS): We are currently looking for a Senior Formulation Scientist - Biologics to join a leading CDMO based in the Berkshire area. As the Senior Formulation Scientist -... Berkshire

Notice NOT-ES-23-014 from the NIH Guide for Grants and Contracts